drugset / Trial / NCT03938740
Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
RandomizedParallel-groupOpen-labelTreatment
Summary
Multi-center, open-label, multiple dose safety, tolerability and efficacy study
Timeline
- Start
- 2019-03-18
- Primary completion
- 2019-12-06
- Completion
- 2020-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Lispro | Protein / enzyme biologic | — | — |
| Subject | insulin degludec | Protein / enzyme biologic | — | — |